Abiochem Biotechnology
Developing new biocatalysis and synthetic biology processes.
Launch date
Employees
Market cap
-
Enterprise valuation
€167—251m (Dealroom.co estimates May 2021.)
Shanghai Shanghai (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Series A | ||
N/A | Series A | ||
$46.0m | Series C | ||
| Total Funding | €41.8m | ||
Related Content
Recent News about Abiochem Biotechnology
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.